Genmab A/S

DUS:GE9

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is GE9's stock price target?

Price Target

339.72 EUR

According to Wall Street analysts, the average 1-year price target for GE9 is 339.72 EUR with a low forecast of 188.38 EUR and a high forecast of 409.86 EUR.

What is the Revenue forecast for Genmab A/S?

Projected CAGR

10%

Over the last 13 years, the compound annual growth rate for Revenue has been 34%. The projected CAGR for the next 8 years is 10%.

What is the Gross Profit forecast for Genmab A/S?

Projected CAGR

7%

The compound annual growth rate for Gross Profit over the next 8 years is 7%.

What is the Operating Income forecast for Genmab A/S?

Projected CAGR

10%

The compound annual growth rate for Operating Income over the next 8 years is 10%.

What is the Pre-Tax Income forecast for Genmab A/S?

Projected CAGR

20%

The compound annual growth rate for Pre-Tax Income over the next 3 years is 20%.

What is the Net Income forecast for Genmab A/S?

Projected CAGR

12%

The compound annual growth rate for Net Income over the next 8 years is 12%.